FOXD2 and rheumatoid arthritis: The overexpressed FOXD2-AS1 increased the proliferation and invasion of fibroblast-like synoviocytes through the miR-331-3p/PIAS3 pathway, suggesting that FOXD2-AS1 may be a promising target for RA treatment (185).